Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?. Reumatismo, [S. l.], v. 77, n. 2, 2025. DOI: 10.4081/reumatismo.2025.1754. Disponível em: https://www.reumatismo.org/reuma/article/view/1754. Acesso em: 26 jun. 2025.